Shikanov S - Search Results

1

Intratumoral delivery of paclitaxel for treatment of orthotopic prostate cancer.

Shikanov S, Shikanov A, Gofrit O, Nyska A, Corn B, Domb AJ. Shikanov S, et al. Among authors: shikanov a. J Pharm Sci. 2009 Mar;98(3):1005-14. doi: 10.1002/jps.21492. J Pharm Sci. 2009. PMID: 18661540

2

Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant.

Shikanov A, Shikanov S, Vaisman B, Golenser J, Domb AJ. Shikanov A, et al. Among authors: shikanov s. Int J Pharm. 2008 Jun 24;358(1-2):114-20. doi: 10.1016/j.ijpharm.2008.02.028. Epub 2008 Mar 8. Int J Pharm. 2008. PMID: 18406086

3

Efficacy of poly(sebacic acid-co-ricinoleic acid) biodegradable delivery system for intratumoral delivery of paclitaxel.

Shikanov A, Vaisman B, Shikanov S, Domb AJ. Shikanov A, et al. Among authors: shikanov s. J Biomed Mater Res A. 2010 Mar 15;92(4):1283-91. doi: 10.1002/jbm.a.32429. J Biomed Mater Res A. 2010. PMID: 19343769

4

Marker lesion experiments in bladder cancer--what have we learned?

Gofrit ON, Zorn KC, Shikanov S, Steinberg GD. Gofrit ON, et al. Among authors: shikanov s. J Urol. 2010 May;183(5):1678-84. doi: 10.1016/j.juro.2009.12.104. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299042 Review.

5

Cisplatin tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant.

Shikanov A, Shikanov S, Vaisman B, Golenser J, Domb AJ. Shikanov A, et al. Among authors: shikanov s. Chemother Res Pract. 2011;2011:175054. doi: 10.1155/2011/175054. Epub 2011 Feb 27. Chemother Res Pract. 2011. PMID: 22295203 Free PMC article.

6

Vesical vs. extra-vesical patterns of recurrence after the treatment of urothelial upper tract tumors.

Shikanov S, Shapiro A, Baer L, Landau EH, Katz R, Gofrit ON. Shikanov S, et al. Urol Oncol. 2008 May-Jun;26(3):266-70. doi: 10.1016/j.urolonc.2007.04.007. Epub 2007 Dec 21. Urol Oncol. 2008. PMID: 18452817

7

How accurate is our clinical prediction of "minimal prostate cancer"?

Leibovici D, Shikanov S, Gofrit ON, Zagaja GP, Shilo Y, Shalhav AL. Leibovici D, et al. Among authors: shikanov s. Isr Med Assoc J. 2013 Jul;15(7):359-63. Isr Med Assoc J. 2013. PMID: 23943981 Free article.

8

A single microfocus (5% or less) of Gleason 6 prostate cancer at biopsy--can we predict adverse pathological outcomes?

Thong AE, Shikanov S, Katz MH, Gofrit ON, Eggener S, Zagaja GP, Shalhav AL, Zorn KC. Thong AE, et al. Among authors: shikanov s. J Urol. 2008 Dec;180(6):2436-40. doi: 10.1016/j.juro.2008.08.027. Epub 2008 Oct 19. J Urol. 2008. PMID: 18930486

9

Is seminal vesiculectomy necessary in all patients with biopsy Gleason score 6?

Gofrit ON, Zorn KC, Shikanov SA, Zagaja GP, Shalhav AL. Gofrit ON, et al. J Endourol. 2009 Apr;23(4):709-13. doi: 10.1089/end.2008.0577. J Endourol. 2009. PMID: 19335331

10

Robotic laparoscopic radical prostatectomy for biopsy Gleason 8 to 10: prediction of favorable pathologic outcome with preoperative parameters.

Shikanov SA, Thong A, Gofrit ON, Zagaja GP, Steinberg GD, Shalhav AL, Zorn KC. Shikanov SA, et al. J Endourol. 2008 Jul;22(7):1477-81. doi: 10.1089/end.2008.0091. J Endourol. 2008. PMID: 18613786

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters